Frank W. Oertel

Director/Board Member at BioAgency AG

Finance

Technology Services

Profile

Frank W.
Oertel is the founder of Indivumed GmbH, which was founded in 2002.
Currently, he holds the position of Member-Supervisory Board at BioAgency AG.

Frank W. Oertel active positions

Companies	Position	Start
BioAgency AG BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany.	Director/Board Member	-

All active positions of Frank W. Oertel

Former positions of Frank W. Oertel

Companies	Position	End
Indivumed GmbH Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.	Founder	-

See the detail of Frank W. Oertel's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank W. Oertel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
BioAgency AG BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany.	Finance
Indivumed GmbH Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.	Technology Services